By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Otic steroids with anti-infectives > Ciprofloxacin and dexamethasone otic > Ciprofloxacin / Dexamethasone Otic Dosage
Otic steroids with anti-infectives
https://themeditary.com/dosage-information/ciprofloxacin-dexamethasone-otic-dosage-11111.html

Ciprofloxacin / Dexamethasone Otic Dosage

Drug Detail:Ciprofloxacin and dexamethasone otic (Ciprofloxacin and dexamethasone otic [ sip-roe-flox-a-sin-and-dex-a-meth-a-sone-oh-tik ])

Drug Class: Otic steroids with anti-infectives

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Otitis Externa

Recommended dose: 4 drops in the affected ear(s) 2 times a day
Duration of therapy: 7 days

Comments:

  • Patients should lie with the affected ear upward before administration. Once instilled, the tragus should be pumped inward 4 times, and the patient should remain in this position for at least 1 minute.
  • If both ears are affected, this procedure should be repeated for the opposite ear.

Use:
  • Treatment of acute otitis externa in patients due to Staphylococcus aureus and/or Pseudomonas aeruginosa

Usual Pediatric Dose for Otitis Media

6 months and older:

  • Recommended dose: 4 drops in the affected ear(s) 2 times a day
  • Duration of therapy: 7 days

Comments:
  • Patients should lie with the affected ear upward before administration. Once instilled, the tragus should be pumped inward 4 times, and the patient should remain in this position for at least 1 minute.
  • If both ears are affected, this procedure should be repeated for the opposite ear.

Uses:
  • Treatment of acute otitis media in patients with tympanostomy tubes due to Staphylococcus aureus, Streptococcus pneumoniae, Moraxella catarrhalis, and/or Pseudomonas aeruginosa
  • Treatment of acute otitis externa in patients due to S aureus and/or P aeruginosa

Usual Pediatric Dose for Otitis Externa

6 months and older:

  • Recommended dose: 4 drops in the affected ear(s) 2 times a day
  • Duration of therapy: 7 days

Comments:
  • Patients should lie with the affected ear upward before administration. Once instilled, the tragus should be pumped inward 4 times, and the patient should remain in this position for at least 1 minute.
  • If both ears are affected, this procedure should be repeated for the opposite ear.

Uses:
  • Treatment of acute otitis media in patients with tympanostomy tubes due to Staphylococcus aureus, Streptococcus pneumoniae, Moraxella catarrhalis, and/or Pseudomonas aeruginosa
  • Treatment of acute otitis externa in patients due to S aureus and/or P aeruginosa

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Safety and efficacy have not been established in patients younger than 6 months

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • Patients should shake the bottle well before use.
  • The vial should be warmed in their hands for 1 to 2 minutes prior to administration to avoid dizziness associated with instillation of a cold solution into the ear canal.

Storage requirements:
  • This drug should be protected from light when not in use. Unused suspension should be discarded at the end of treatment.

General:
  • Each dose of 4 drops delivers 0.14 mL, which is equivalent to 0.42 mg of ciprofloxacin and 0.14 mg dexamethasone.
  • Limitations of use: This drug is indicated for otic use only. It is not indicated for ophthalmic use or injection.

Monitoring:
  • Tendon inflammation/pain/rupture

Patient advice:
  • Tell patients that this drug is for otic use only.
  • Patients should be instructed to wash their hands before and after applying this drug. During instillation, patients should be told to avoid contamination caused by touching the tip to the surface of the eye, fingers, etc.
  • Caution patients to warm the vial in the hands for 1 to 2 minutes to prevent dizziness during administration.
Patients should be told to immediately report any signs/symptoms of tendon inflammation/rupture or hypersensitivities reactions.
  • Patients should be encouraged to avoid missing doses and complete the entire course of therapy. Remaining suspension should be discarded at the end of treatment.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by